Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADORA3 | P0DMS8 | 20/20 | 0.64 |
| ▸ | ADORA1 | P30542 | 11/20 | 0.62 |
| ▸ | ADORA2B | P29275 | 8/20 | 0.62 |
| ▸ | ADORA2A | P29274 | 7/20 | 0.62 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22750604 | 0.97 | ADORA3 (0.67) | ADORA3ADORA1ADORA2BADORA2A | |
| SCHEMBL22750493 | 0.91 | ADORA3 (0.65) | ADORA3ADORA1ADORA2BADORA2A | |
| SCHEMBL22757416 | 0.90 | ADORA3 (0.66) | ADORA3ADORA1ADORA2BADORA2A | |
| SCHEMBL22750480 | 0.90 | ADORA3 (0.66) | ADORA3ADORA1ADORA2BADORA2A | |
| SCHEMBL22750563 | 0.87 | ADORA3 (0.63) | ADORA3ADORA1ADORA2BADORA2A | |
| SCHEMBL22750581 | 0.82 | ADORA3 (0.69) | ADORA3ADORA1ADORA2BADORA2A | |
| SCHEMBL22750642 | 0.79 | ADORA3 (0.70) | ADORA3ADORA1ADORA2BADORA2A | |
| SCHEMBL22757514 | 0.79 | ADORA3 (0.70) | ADORA3ADORA1ADORA2BADORA2A | |
| SCHEMBL22750518 | 0.79 | ADORA3 (0.65) | ADORA3ADORA1ADORA2BADORA2A | |
| SCHEMBL22750585 | 0.77 | ADORA3 (0.69) | ADORA3ADORA1ADORA2BADORA2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2020247546-A1 | ADENOSINE ANALOGS FOR THE TREATMENT OF DISEASE | BIOINTERVENE, INC. (US) | 2020-12-10 | — | — | WO | disclosed |
| WO-2020247546-A1 | ADENOSINE ANALOGS FOR THE TREATMENT OF DISEASE | BIOINTERVENE, INC. (US) | 2020-12-10 | — | — | WO | disclosed |